Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The principle aim of this study is to obtain safety, tolerability and pharmacokinetic data
when LEO 39652 cream is administered cutaneously as single dose to subjects with atopic
dermatitis and to healthy subjects.